Heart disease remains the leading cause of death in adults over 65, yet most cardiology protocols were developed in clinical trials that systematically excluded older patients — particularly those with frailty, cognitive decline, or multiple chronic conditions. A new scientific statement from the American College of Cardiology directly challenges this mismatch, arguing that standard cardiovascular care must be restructured to account for the biological and functional realities of aging.
The ACC statement calls for routine integration of geriatric assessment tools into cardiovascular practice, including evaluation of frailty status, cognitive function, and patient-defined health priorities. Rather than defaulting to aggressive intervention benchmarks designed for younger cohorts, the framework advocates for individualized decision-making that weighs procedural risk against functional benefit. The statement also highlights polypharmacy as a critical concern: older cardiac patients often carry five or more concurrent medications, dramatically elevating adverse event risk when standard cardioprotective regimens are added without reconciliation.
This represents a meaningful institutional shift. For decades, cardiology and geriatrics have operated as parallel disciplines, with older patients frequently receiving care optimized for younger physiology. The ACC statement aligns with a growing body of evidence — including the FRAILTY-AVR and SENIOR-RITA trials — demonstrating that frailty indices predict cardiovascular outcomes independent of traditional risk factors like ejection fraction or lipid levels. That an organization as influential as the ACC is formalizing this integration into official guidance elevates it from academic consensus to clinical expectation. The primary limitation here is that scientific statements carry advisory rather than mandatory weight, and implementation across diverse practice settings will be uneven. Still, for a field where age-related undertreatment and overtreatment both cause measurable harm, this statement is more than incremental — it is a structural course correction that could meaningfully reshape how cardiologists approach their fastest-growing patient population.
